INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $976.0K | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | $1.03M | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | $994.0K | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | $989.0K | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.11M | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | $1.20M | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $1.16M | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | $1.18M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $2.47M | Mar 20, 2025 |
| FY2024 | Sep 30, 2023 | $1.64M | Mar 20, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($101.0K) | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | ($90.0K) | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | ($97.0K) | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | ($95.0K) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($106.0K) | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | ($97.0K) | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | ($114.0K) | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | ($95.0K) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($30.0K) | Mar 20, 2025 |
| FY2024 | Sep 30, 2023 | ($437.0K) | Mar 20, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($77.0K) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $713.0K | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $973.0K | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $4.0K | Mar 20, 2025 |
| FY2023 | Dec 31, 2021 | ($2.98M) | Mar 21, 2024 |
| FY2022 | Dec 31, 2020 | $7.0K | Mar 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.0K | Mar 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.63M | Mar 29, 2021 |
| FY2019 | Dec 31, 2017 | $2.78M | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | $3.45M | Apr 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $125.92M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $121.93M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $118.08M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $111.99M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $108.07M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $104.47M | Mar 25, 2022 |
| FY2020 | Dec 31, 2019 | $100.26M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $96.12M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $87.90M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $86.40M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $12.0K | Mar 29, 2021 |
| FY2020 | Dec 31, 2019 | $14.0K | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $26.0K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $10.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $23.0K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $6.0K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $10.28M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $12.57M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $28.7K | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $33.84M | Apr 16, 2013 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $125.92M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $121.93M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $118.08M | Mar 12, 2026 |
| FY2025 | Dec 31, 2022 | $111.99M | Mar 12, 2026 |
| FY2024 | Dec 31, 2021 | $108.05M | Mar 20, 2025 |
| FY2023 | Dec 31, 2020 | $104.46M | Mar 21, 2024 |
| FY2022 | Dec 31, 2019 | $100.24M | Mar 23, 2023 |
| FY2021 | Dec 31, 2018 | $96.10M | Mar 25, 2022 |
| FY2020 | Dec 31, 2017 | $87.89M | Mar 29, 2021 |
| FY2019 | Dec 31, 2016 | $86.38M | Mar 24, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.67M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $61.68M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $57.03M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $50.03M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $46.10M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $42.50M | Mar 25, 2022 |
| FY2020 | Dec 31, 2019 | $38.28M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $34.14M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $25.93M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $24.42M | Apr 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.0K | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $9.0K | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $71.0K | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $6.0K | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $2.0K | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $12.0K | Mar 25, 2022 |
| FY2020 | Dec 31, 2019 | $5.0K | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $4.0K | Mar 24, 2020 |
| FY2019 | Dec 31, 2017 | $2.0K | Mar 24, 2020 |
| FY2019 | Dec 31, 2016 | $1.0K | Mar 24, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 20, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 20, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 20, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 20, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.07M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 4.07M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 4.11M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | 4.17M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | 4.17M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 4.17M | Mar 25, 2022 |
| FY2020 | Dec 31, 2019 | 4.17M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | 4.17M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | 4.17M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 4.17M | Apr 2, 2018 |